Publicaciones en colaboración con investigadores/as de Rockefeller University (25)

2024

  1. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

    Genome medicine

  2. The immunopathological landscape of human pre-TCRa deficiency: From rare to common variants

    Science, Vol. 383, Núm. 6686

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Inherited human ezrin deficiency impairs adaptive immunity

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 997-1009.e11

  3. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  4. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

    Science immunology, Vol. 8, Núm. 90, pp. eabp8966

2022

  1. Human genetic and immunological determinants of critical COVID-19 pneumonia

    Nature, Vol. 603, Núm. 7902, pp. 587-598

2021

  1. Clinical and Immunological Features of Human BCL10 Deficiency

    Frontiers in Immunology, Vol. 12

  2. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

    Science immunology, Vol. 6, Núm. 62

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Human BCL10 Deficiency due to Homozygosity for a Rare Allele

    Journal of Clinical Immunology, Vol. 40, Núm. 2, pp. 388-398

  3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

2019

  1. Double-strand break repair through homologous recombination in autosomal-recessive BCL10 deficiency

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 5, pp. 1931-1934.e1

2018

  1. Disseminated abscesses due to Mycoplasma faucium in a patient with activated PI3Kδ syndrome type 2

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 6, Núm. 5, pp. 1796-1798.e2

  2. Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines

    PLoS ONE, Vol. 13, Núm. 1

2017

  1. Inhibiting the Plasmodium eIF2α Kinase PK4 Prevents Artemisinin-Induced Latency

    Cell Host and Microbe, Vol. 22, Núm. 6, pp. 766-776.e4

  2. Population mechanics: A mathematical framework to study T cell homeostasis

    Scientific Reports, Vol. 7, Núm. 1

  3. Viral vector vaccines for liver-stage malaria

    Malaria: Immune Response to Infection and Vaccination (Springer International Publishing), pp. 157-169

2016

  1. Actin polymerisation after FCγR stimulation of human fibroblasts is BCL10 independent

    Clinical Immunology

  2. Gain-of-function mutation in PIK3R1 in a patient with a narrow clinical phenotype of respiratory infections

    Clinical Immunology